REGN logo

REGN EBIT

Annual EBIT

$4.84 B
+$562.80 M+13.17%

December 31, 2024


Summary


Performance

REGN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREGNprofitabilitymetrics:

Quarterly EBIT

$968.60 M
-$538.20 M-35.72%

December 31, 2024


Summary


Performance

REGN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREGNprofitabilitymetrics:

TTM EBIT

$4.84 B
-$197.30 M-3.92%

December 31, 2024


Summary


Performance

REGN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherREGNprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

REGN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.2%-16.9%+13.2%
3 y3 years-48.5%-16.9%+13.2%
5 y5 years+96.6%-16.9%+13.2%

REGN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.5%+13.2%-61.5%+35.1%-48.5%+17.6%
5 y5-year-48.5%+96.6%-74.3%+43.6%-48.5%+96.6%
alltimeall time-48.5%+2498.2%-74.3%+1732.8%-48.5%+2498.2%

Regeneron Pharmaceuticals EBIT History

DateAnnualQuarterlyTTM
Dec 2024
$4.84 B(+13.2%)
$968.60 M(-35.7%)
$4.84 B(-3.9%)
Sep 2024
-
$1.51 B(-8.3%)
$5.03 B(+8.1%)
Jun 2024
-
$1.64 B(+129.2%)
$4.65 B(+13.2%)
Mar 2024
-
$716.80 M(-38.5%)
$4.11 B(-3.7%)
Dec 2023
$4.27 B(-13.1%)
$1.17 B(+3.3%)
$4.27 B(-4.0%)
Sep 2023
-
$1.13 B(+2.4%)
$4.45 B(-8.2%)
Jun 2023
-
$1.10 B(+25.8%)
$4.84 B(+2.7%)
Mar 2023
-
$876.00 M(-34.7%)
$4.72 B(-4.0%)
Dec 2022
$4.92 B(-47.6%)
$1.34 B(-12.0%)
$4.92 B(-19.3%)
Sep 2022
-
$1.53 B(+56.2%)
$6.09 B(-4.8%)
Jun 2022
-
$976.30 M(-9.2%)
$6.40 B(-30.4%)
Mar 2022
-
$1.07 B(-57.3%)
$9.19 B(-2.1%)
Dec 2021
$9.38 B(+142.6%)
$2.52 B(+37.5%)
$9.38 B(+15.8%)
Sep 2021
-
$1.83 B(-51.4%)
$8.11 B(+11.0%)
Jun 2021
-
$3.77 B(+197.2%)
$7.30 B(+63.6%)
Mar 2021
-
$1.27 B(+2.3%)
$4.46 B(+15.3%)
Dec 2020
$3.87 B(+57.3%)
$1.24 B(+21.0%)
$3.87 B(+9.7%)
Sep 2020
-
$1.02 B(+10.3%)
$3.52 B(+7.6%)
Jun 2020
-
$928.60 M(+37.6%)
$3.28 B(+27.0%)
Mar 2020
-
$674.70 M(-24.7%)
$2.58 B(+4.9%)
Dec 2019
$2.46 B(-4.7%)
$896.50 M(+15.5%)
$2.46 B(+9.5%)
Sep 2019
-
$776.30 M(+233.6%)
$2.25 B(+6.3%)
Jun 2019
-
$232.70 M(-58.0%)
$2.11 B(-16.9%)
Mar 2019
-
$553.80 M(-19.0%)
$2.54 B(-1.5%)
Dec 2018
$2.58 B(+22.7%)
$683.60 M(+6.3%)
$2.58 B(+5.0%)
Sep 2018
-
$643.30 M(-3.0%)
$2.46 B(+3.0%)
Jun 2018
-
$663.00 M(+12.0%)
$2.39 B(+5.8%)
Mar 2018
-
$591.80 M(+5.5%)
$2.26 B(+7.2%)
Dec 2017
$2.10 B(+57.3%)
$560.77 M(-1.9%)
$2.10 B(+11.5%)
Sep 2017
-
$571.79 M(+7.6%)
$1.89 B(+12.2%)
Jun 2017
-
$531.25 M(+20.8%)
$1.68 B(+16.5%)
Mar 2017
-
$439.79 M(+27.7%)
$1.44 B(+8.0%)
Dec 2016
$1.34 B(+7.9%)
$344.32 M(-6.0%)
$1.34 B(+10.8%)
Sep 2016
-
$366.38 M(+24.8%)
$1.21 B(-2.3%)
Jun 2016
-
$293.51 M(-11.8%)
$1.24 B(-4.1%)
Mar 2016
-
$332.79 M(+55.1%)
$1.29 B(+4.0%)
Dec 2015
$1.24 B(+55.2%)
$214.53 M(-45.6%)
$1.24 B(+1.5%)
Sep 2015
-
$394.56 M(+13.9%)
$1.22 B(+20.0%)
Jun 2015
-
$346.51 M(+22.1%)
$1.02 B(+14.3%)
Mar 2015
-
$283.73 M(+44.7%)
$889.84 M(+11.4%)
Dec 2014
$798.61 M(+7.5%)
$196.07 M(+2.6%)
$798.61 M(+0.4%)
Sep 2014
-
$191.06 M(-12.8%)
$795.37 M(-5.5%)
Jun 2014
-
$218.98 M(+13.8%)
$841.74 M(+7.7%)
Mar 2014
-
$192.50 M(-0.2%)
$781.81 M(+5.2%)
Dec 2013
$742.82 M(+61.6%)
$192.84 M(-18.8%)
$742.82 M(+6.7%)
Sep 2013
-
$237.42 M(+49.3%)
$696.04 M(+5.2%)
Jun 2013
-
$159.06 M(+3.6%)
$661.50 M(+12.0%)
Mar 2013
-
$153.51 M(+5.1%)
$590.42 M(+28.4%)
Dec 2012
$459.73 M(-328.0%)
$146.05 M(-28.0%)
$459.73 M(+70.9%)
Sep 2012
-
$202.88 M(+130.6%)
$269.07 M(+3086.1%)
Jun 2012
-
$87.98 M(+285.7%)
$8.45 M(-106.1%)
Mar 2012
-
$22.81 M(-151.1%)
-$138.85 M(-31.1%)
Dec 2011
-$201.61 M(+111.4%)
-$44.60 M(-22.8%)
-$201.61 M(+19.2%)
Sep 2011
-
-$57.74 M(-2.7%)
-$169.15 M(+18.2%)
Jun 2011
-
-$59.32 M(+48.5%)
-$143.04 M(+33.9%)
Mar 2011
-
-$39.94 M(+229.1%)
-$106.86 M(+12.1%)
Dec 2010
-$95.35 M(+37.0%)
-$12.14 M(-61.6%)
-$95.35 M(-19.3%)
Sep 2010
-
-$31.64 M(+36.8%)
-$118.13 M(+34.6%)
Jun 2010
-
-$23.13 M(-18.7%)
-$87.78 M(+8.5%)
Mar 2010
-
-$28.44 M(-18.6%)
-$80.92 M(+19.2%)
Dec 2009
-$69.61 M(+0.9%)
-$34.92 M(+2604.9%)
-$67.86 M(+45.2%)
Sep 2009
-
-$1.29 M(-92.1%)
-$46.74 M(-28.5%)
Jun 2009
-
-$16.27 M(+5.7%)
-$65.38 M(-4.9%)
Mar 2009
-
-$15.39 M(+11.5%)
-$68.73 M(-0.8%)
Dec 2008
-$69.03 M(-26.2%)
-$13.79 M(-30.8%)
-$69.26 M(+50.2%)
Sep 2008
-
-$19.93 M(+1.6%)
-$46.10 M(-28.9%)
Jun 2008
-
-$19.62 M(+23.3%)
-$64.83 M(-14.5%)
Mar 2008
-
-$15.91 M(-269.9%)
-$75.82 M(-19.0%)
Dec 2007
-$93.56 M
$9.36 M(-124.2%)
-$93.56 M(-31.4%)
Sep 2007
-
-$38.67 M(+26.3%)
-$136.41 M(+8.3%)
DateAnnualQuarterlyTTM
Jun 2007
-
-$30.60 M(-9.0%)
-$126.00 M(+5.3%)
Mar 2007
-
-$33.65 M(+0.5%)
-$119.64 M(+11.1%)
Dec 2006
-$107.66 M(-186.5%)
-$33.49 M(+18.5%)
-$107.66 M(-174.2%)
Sep 2006
-
-$28.26 M(+16.5%)
$145.15 M(+4.4%)
Jun 2006
-
-$24.25 M(+11.9%)
$139.02 M(+6.0%)
Mar 2006
-
-$21.66 M(-109.9%)
$131.10 M(+5.4%)
Dec 2005
$124.42 M(+2103.7%)
$219.31 M(-737.8%)
$124.42 M(-236.8%)
Sep 2005
-
-$34.39 M(+6.9%)
-$90.92 M(+37.7%)
Jun 2005
-
-$32.17 M(+13.5%)
-$66.01 M(+42.0%)
Mar 2005
-
-$28.34 M(-813.1%)
-$46.49 M(-923.4%)
Dec 2004
$5.65 M(-105.6%)
$3.97 M(-141.9%)
$5.65 M(-136.5%)
Sep 2004
-
-$9.48 M(-25.0%)
-$15.47 M(-51.2%)
Jun 2004
-
-$12.64 M(-153.1%)
-$31.69 M(-33.4%)
Mar 2004
-
$23.79 M(-238.8%)
-$47.60 M(-52.3%)
Dec 2003
-$99.99 M(-18.0%)
-$17.14 M(-33.3%)
-$99.78 M(-14.9%)
Sep 2003
-
-$25.70 M(-10.0%)
-$117.27 M(-5.2%)
Jun 2003
-
-$28.56 M(+0.6%)
-$123.74 M(-1.1%)
Mar 2003
-
-$28.38 M(-18.1%)
-$125.14 M(+2.6%)
Dec 2002
-$121.95 M(+42.3%)
-$34.63 M(+7.6%)
-$121.95 M(+4.3%)
Sep 2002
-
-$32.18 M(+7.4%)
-$116.91 M(+8.2%)
Jun 2002
-
-$29.95 M(+18.9%)
-$108.03 M(+12.3%)
Mar 2002
-
-$25.19 M(-14.9%)
-$96.17 M(+12.2%)
Dec 2001
-$85.68 M(+239.0%)
-$29.59 M(+27.0%)
-$85.68 M(+30.1%)
Sep 2001
-
-$23.29 M(+28.8%)
-$65.88 M(+13.4%)
Jun 2001
-
-$18.09 M(+22.9%)
-$58.07 M(+32.4%)
Mar 2001
-
-$14.71 M(+50.3%)
-$43.87 M(+16.6%)
Dec 2000
-$25.28 M(+6.2%)
-$9.79 M(-36.8%)
-$37.64 M(+31.8%)
Sep 2000
-
-$15.49 M(+298.9%)
-$28.55 M(+57.2%)
Jun 2000
-
-$3.88 M(-54.2%)
-$18.16 M(-19.9%)
Mar 2000
-
-$8.48 M(+1111.4%)
-$22.68 M(-7.8%)
Dec 1999
-$23.80 M(+90.4%)
-$700.00 K(-86.3%)
-$24.60 M(-17.7%)
Sep 1999
-
-$5.10 M(-39.3%)
-$29.90 M(+9.9%)
Jun 1999
-
-$8.40 M(-19.2%)
-$27.20 M(+50.3%)
Mar 1999
-
-$10.40 M(+73.3%)
-$18.10 M(+43.7%)
Dec 1998
-$12.50 M(-8.8%)
-$6.00 M(+150.0%)
-$12.60 M(+8.6%)
Sep 1998
-
-$2.40 M(-442.9%)
-$11.60 M(+12.6%)
Jun 1998
-
$700.00 K(-114.3%)
-$10.30 M(-29.9%)
Mar 1998
-
-$4.90 M(-2.0%)
-$14.70 M(+5.8%)
Dec 1997
-$13.70 M(-20.8%)
-$5.00 M(+354.5%)
-$13.90 M(+3.7%)
Sep 1997
-
-$1.10 M(-70.3%)
-$13.40 M(-19.8%)
Jun 1997
-
-$3.70 M(-9.8%)
-$16.70 M(0.0%)
Mar 1997
-
-$4.10 M(-8.9%)
-$16.70 M(-3.5%)
Dec 1996
-$17.30 M(+127.6%)
-$4.50 M(+2.3%)
-$17.30 M(+11.6%)
Sep 1996
-
-$4.40 M(+18.9%)
-$15.50 M(+14.8%)
Jun 1996
-
-$3.70 M(-21.3%)
-$13.50 M(+21.6%)
Mar 1996
-
-$4.70 M(+74.1%)
-$11.10 M(+30.6%)
Dec 1995
-$7.60 M(-74.0%)
-$2.70 M(+12.5%)
-$8.50 M(-22.0%)
Sep 1995
-
-$2.40 M(+84.6%)
-$10.90 M(-10.7%)
Jun 1995
-
-$1.30 M(-38.1%)
-$12.20 M(-41.6%)
Mar 1995
-
-$2.10 M(-58.8%)
-$20.90 M(-28.4%)
Dec 1994
-$29.20 M(-24.7%)
-$5.10 M(+37.8%)
-$29.20 M(-17.3%)
Sep 1994
-
-$3.70 M(-63.0%)
-$35.30 M(-13.7%)
Jun 1994
-
-$10.00 M(-3.8%)
-$40.90 M(+0.5%)
Mar 1994
-
-$10.40 M(-7.1%)
-$40.70 M(+3.0%)
Dec 1993
-$38.80 M(+112.0%)
-$11.20 M(+20.4%)
-$39.50 M(+14.8%)
Sep 1993
-
-$9.30 M(-5.1%)
-$34.40 M(+12.1%)
Jun 1993
-
-$9.80 M(+6.5%)
-$30.70 M(+25.8%)
Mar 1993
-
-$9.20 M(+50.8%)
-$24.40 M(+32.6%)
Dec 1992
-$18.30 M(+90.6%)
-$6.10 M(+8.9%)
-$18.40 M(+15.0%)
Sep 1992
-
-$5.60 M(+60.0%)
-$16.00 M(+24.0%)
Jun 1992
-
-$3.50 M(+9.4%)
-$12.90 M(+13.2%)
Mar 1992
-
-$3.20 M(-13.5%)
-$11.40 M(+83.9%)
Dec 1991
-$9.60 M(+190.9%)
-$3.70 M(+48.0%)
-$6.20 M(-34.7%)
Sep 1991
-
-$2.50 M(+25.0%)
-$9.50 M(+66.7%)
Jun 1991
-
-$2.00 M(-200.0%)
-$5.70 M(+128.0%)
Mar 1991
-
$2.00 M(-128.6%)
-$2.50 M(-24.2%)
Dec 1990
-$3.30 M
-$7.00 M(-638.5%)
-$3.30 M(-189.2%)
Sep 1990
-
$1.30 M(+8.3%)
$3.70 M(+54.2%)
Jun 1990
-
$1.20 M(0.0%)
$2.40 M(+100.0%)
Mar 1990
-
$1.20 M
$1.20 M

FAQ

  • What is Regeneron Pharmaceuticals annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual EBIT year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly EBIT year-on-year change?
  • What is Regeneron Pharmaceuticals TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM EBIT year-on-year change?

What is Regeneron Pharmaceuticals annual earnings before interest & taxes?

The current annual EBIT of REGN is $4.84 B

What is the all time high annual EBIT for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual earnings before interest & taxes is $9.38 B

What is Regeneron Pharmaceuticals annual EBIT year-on-year change?

Over the past year, REGN annual earnings before interest & taxes has changed by +$562.80 M (+13.17%)

What is Regeneron Pharmaceuticals quarterly earnings before interest & taxes?

The current quarterly EBIT of REGN is $968.60 M

What is the all time high quarterly EBIT for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly earnings before interest & taxes is $3.77 B

What is Regeneron Pharmaceuticals quarterly EBIT year-on-year change?

Over the past year, REGN quarterly earnings before interest & taxes has changed by -$197.30 M (-16.92%)

What is Regeneron Pharmaceuticals TTM earnings before interest & taxes?

The current TTM EBIT of REGN is $4.84 B

What is the all time high TTM EBIT for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM earnings before interest & taxes is $9.38 B

What is Regeneron Pharmaceuticals TTM EBIT year-on-year change?

Over the past year, REGN TTM earnings before interest & taxes has changed by +$562.80 M (+13.17%)